Ozmen M Mahir, Zulfikaroglu Baris, Kucuk N Ozlem, Ozalp Necdet, Aras Gulseren, Koseoglu Tankut, Koç Mahmut
Department of Surgery, Ankara Numune Teaching and Research Hospital, Ankarra, Turkey.
Ann R Coll Surg Engl. 2006 Nov;88(7):632-8. doi: 10.1308/003588406X149200.
Involvement of regional lymph node is a critical sign in prognosis of gastric cancer. Radiological techniques are commonly used to evaluate the extension of gastric cancer. But their sensitivity and specificity are low especially in the early stage. Our aim was to assess the value of gastric lymphoscintigraphy in identifying regional lymph node involvement in patients with gastric cancer, as compared to the abdominal ultrasonography, computed tomography and postoperative histopathological evaluation.
50 patients (12 females) with a median age of 61 years (range, 35-73 years) were included in the study. Pre-operative staging in all cases included upper gastrointestinal endoscopy and biopsy, followed by ultrasound, computed tomography and lymphoscintigraphy. 148 MBq Technetium-99m lymphoscint was injected around the tumour during endoscopy and immediately after injection, anterior, lateral and posterior images were taken in 5-min intervals using a gamma camera. Findings were compared to the findings of other tests. The sensitivity, specificity, positive predictive value, and negative predictive value of each test were calculated and compared.
Histologically, 68% of cases (34/50) had metastasis in regional lymph nodes and all cases were accurately diagnosed by lymphoscintigraphy. Lymphoscintigraphy was significantly more sensitive for detecting lymph node involvement (P < 0.01). Both abdominal ultrasonography and CT had very low sensitivity in identifying lymph nodes.
Lymphoscintigraphy is a promising test in the identification of regional lymph nodes pre-operatively in patients with gastric cancer. It might help the surgeon to plan the extent of dissection before surgery which may decrease postoperative complications related to unnecessary extensive lymph node dissection.
区域淋巴结受累是胃癌预后的关键指标。放射学技术常用于评估胃癌的扩散情况。但其敏感性和特异性较低,尤其是在早期阶段。我们的目的是评估胃淋巴闪烁显像术在识别胃癌患者区域淋巴结受累方面的价值,并与腹部超声、计算机断层扫描和术后组织病理学评估进行比较。
本研究纳入了50例患者(12例女性),中位年龄为61岁(范围35 - 73岁)。所有病例的术前分期包括上消化道内镜检查和活检,随后进行超声、计算机断层扫描和淋巴闪烁显像术。在内镜检查期间,于肿瘤周围注射148 MBq的锝-99m淋巴闪烁显像剂,注射后立即使用γ相机以5分钟的间隔拍摄前位、侧位和后位图像。将结果与其他检查的结果进行比较。计算并比较每项检查的敏感性、特异性、阳性预测值和阴性预测值。
组织学检查显示,68%的病例(34/50)区域淋巴结有转移,所有病例均通过淋巴闪烁显像术准确诊断。淋巴闪烁显像术在检测淋巴结受累方面明显更敏感(P < 0.01)。腹部超声和CT在识别淋巴结方面的敏感性都非常低。
淋巴闪烁显像术在术前识别胃癌患者区域淋巴结方面是一项有前景的检查。它可能有助于外科医生在手术前规划切除范围,这可能会减少与不必要的广泛淋巴结清扫相关的术后并发症。